Nasdaq podd.
According to the issued ratings of 17 analysts in the last year, the consensus rating for Insulet stock is Moderate Buy based on the current 6 hold ratings and 11 buy ratings for PODD. The average twelve-month price prediction for Insulet is $254.80 with a high price target of $350.00 and a low price target of $162.00.
Insulet Corporation (NASDAQ:PODD)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting 0.83. At the close of trading, the stock’s price was $140.44, to imply an increase of 1.98% or $2.72 in intraday trading. The PODD share’s 52-week high ...PODD Most Active Options. Most Active LEAPS Data is currently not available. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ...Nov 29, 2023 · See the latest Insulet Corp stock price (PODD:XNAS), related news, valuation, dividends and more to help you make your investing decisions. NASDAQ:PODD opened at $187.95 on Friday. Insulet Co. has a twelve month low of $125.82 and a twelve month high of $335.91. The company has a current ratio of 3.26, a quick ratio of 2.35 and a debt ...
PODD Insulet Corp NASDAQ 188.51 -0.41 -0.22% Opening 13:12 11/30 EST OPEN 188.80 PREV CLOSE 188.92 HIGH 190.29 LOW 185.73 VOLUME 276.05K TURNOVER 0 52 …Nov 29, 2023 · The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on Friday, November 3, 2023.The analyst firm set a price target for 250.00 expecting PODD to rise to within 12 ...
In the latest trading session, Insulet (PODD) closed at $280.36, marking a -0.97% move from the previous day. This move was narrower than the S&P 500's daily loss of 1.45%. Elsewhere, the Dow lost ...Insulet (NASDAQ:PODD), the manufacturer of the tubeless insulin pump Omnipod, has reached the point of declining sales growth. The company operates in a fiercely competitive industry, ...
The forecasts range from a low of 322.19 to a high of $414.75. The average price target represents an increase of 57.05% from its latest reported closing price of 229.69. See our leaderboard of ...A high-level overview of Insulet Corporation (PODD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The following insiders have purchased PODD shares in the last 24 months: James Hollingshead ($1,006,825.50), and Prem Singh ($168.92). How much insider buying is happening at Insulet? Insiders have purchased a total of 5,551 PODD shares in the last 24 months for a total of $1,006,994.42 bought.The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on November 3, 2023.The analyst firm set a price target for $250.00 expecting PODD to rise to within 12 months (a ...
Find the latest Earnings Report Date for Insulet Corporation Common Stock (PODD) at Nasdaq.com.
Dec 4, 2023 · In the last 3 months, 8 analysts have offered 12-month price targets for Insulet. The company has an average price target of $212.25 with a high of $250.00 and a low of $162.00. Below is a summary ...
188.51. -0.22%. You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform. Webull offers PODD Ent Holdg (PODD) historical stock prices, in-depth market analysis, NASDAQ: PODD real-time stock quote data, in-depth charts, free PODD options chain data, and a fully built financial ...In the latest trading session, Insulet (PODD) closed at $305.89, marking a -0.13% move from the previous day. This change lagged the S&P 500's 0.4% gain on the day. Meanwhile, the Dow gained 0.33% ...Insulet (NASDAQ:PODD - Get Free Report) was upgraded by stock analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research …The consensus estimate for Insulet’s current full-year earnings is $1.90 per share. Get Insulet alerts: Insulet ( NASDAQ:PODD – Get Free Report) last announced its earnings results on Thursday, November 2nd. The medical instruments supplier reported $0.71 EPS for the quarter, topping the consensus estimate of $0.40 by $0.31.Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods.View the latest Insulet Corp. (PODD) stock price, news, historical charts, analyst ratings and financial information from WSJ.Mar 10, 2023 · In the latest trading session, Insulet (PODD) closed at $280.36, marking a -0.97% move from the previous day. This move was narrower than the S&P 500's daily loss of 1.45%. Elsewhere, the Dow lost ...
Jan 12, 2023 · Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. Insulet, with stock symbol PODD, is a company originating in United States and listed on NASDAQ working in Health Care.The stock of Insulet ( NASDAQ:PODD) appears to be significantly undervalued based on GuruFocus' valuation method. With its current price of $230.76 per share and a market cap of $16.10 billion ...Fintel reports that on July 11, 2023, Citigroup maintained coverage of Insulet (NASDAQ:PODD) with a Neutral recommendation.. Analyst Price Forecast Suggests 26.56% Upside. As of July 6, 2023, the ...Insulet Corporation (NASDAQ:PODD) trade information. Sporting 3.82% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, 11/13/23 when the PODD stock price touched $169.96 or saw a rise of 2.8%.PODD Most Active Options. Most Active LEAPS Data is currently not available. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ...Ossiam lifted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 51.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...
Insulet Corporation PODD recently presented new Omnipod 5 Automated Insulin Delivery System (Omnipod 5) study outcomes for children with type 1 diabetes, aged 2 through 5.9 years, at the American ...
We think that Insulet stock (NASDAQ: PODD), a company best known for selling the Omnipod continuous insulin delivery system that caters to people with diabetes, currently is a better pick compared ...“Insulet Corporation (NASDAQ:PODD) is a medical device company focused on the design, development, and commercialization of insulin pump systems for people with type-1 diabetes. Diabetes is a ...Stock analysis for Insulet Corp (PODD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on November 3, 2023.The analyst firm set a price target for $250.00 expecting PODD to rise to within 12 months (a ... Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation.. Analyst Price Forecast Suggests 109.29% Upside. As of October 5 ...Insulet (PODD) closed the most recent trading day at $296.27, moving +1.35% from the previous trading session. This change outpaced the S&P 500's 0.08% loss on the day. At the same time, the Dow ...Insulet Corporation PODD reported adjusted earnings per share (EPS) of 38 cents for second-quarter 2023, marking a significant improvement from the year-ago period’s adjusted net loss of 6 cents ...
Insulet Corporation (NASDAQ:PODD)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting 0.83. At the close of trading, the stock’s price was $140.44, to imply an increase of 1.98% or $2.72 in intraday trading. The PODD share’s 52-week high ...
Find the latest SEC Filings data for Insulet Corporation Common Stock (PODD) at Nasdaq.com.
Aug 2, 2023 · The forecasts range from a low of 322.19 to a high of $414.75. The average price target represents an increase of 57.05% from its latest reported closing price of 229.69. See our leaderboard of ... Nov 29, 2023 · The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on Friday, November 3, 2023.The analyst firm set a price target for 250.00 expecting PODD to rise to within 12 ... May 23, 2023 — 08:25 am EDT Written by Zacks Equity Research for Zacks -> Insulet Corporation PODD is well-poised for growth in the coming quarters, backed by strength …Insulet Stock Price, News & Analysis (NASDAQ:PODD) NASDAQ:PODD Insulet (PODD) Stock Price, News & Analysis $186.31 +4.99 (+2.75%) (As of 11/22/2023 …Nov 14, 2023 · Insulet Corporation (NASDAQ: PODD)’s stock price has gone rise by 5.55 in comparison to its previous close of 155.10, however, the company has experienced a 3.01% increase in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns because of its solid growth attributes. […] On March 10, 2023, Insulet Corporation (NASDAQ:PODD) stock closed at $280.36 per share. One-month return of Insulet Corporation (NASDAQ:PODD) was -6.11%, and its shares gained 32.27% of their ...The stock has gained 47.7% compared with the industry’s 15.1% rise. Insulet exited the second quarter of 2021 with better-than-expected revenues. The year-over-year improvement in the top line ...... NASDAQ: PODD Insulet.com. Makers of the Omnipod® Insulin Management System. DRAFT nn January 2021. URGENT: FIELD SAFETY NOTICE. Urgent Information Regarding the ...
Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger Jul 31. Insulet Corporation to Report Q2, 2023 Results on Aug 08, 2023. Jul 06. Insulet Corporation Announces Omnipod 5 Automated Insulin Delivery System Is Now Available in the United Kingdom Jun 21.Insulet Corporation (NASDAQ:NASDAQ:PODD) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ETCompany ParticipantsDeborah Gordon - Vice President,...Nov 29, 2023 · How much is Insulet stock worth today? ( NASDAQ: PODD) Insulet currently has 69,821,118 outstanding shares. With Insulet stock trading at $162.58 per share, the total value of Insulet stock (market capitalization) is $11.35B. Insulet stock was originally listed at a price of $15.96 in May 15, 2007. 05-Dec-2022 ... To wit, the Insulet Corporation (NASDAQ:PODD) share price has soared 342% over five years. And this is just one example of the epic gains ...Instagram:https://instagram. scotts liquid goldtequila stocksinsidermonkeygood mobile banking apps Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed started increasing rates, compared to 14% gains ... es minigood defensive stocks Nov 20, 2023 · Turning to the calls side of the option chain, the call contract at the $180.00 strike price has a current bid of $34.30. If an investor was to purchase shares of PODD stock at the current price ... Insulet Corporation (NASDAQ:PODD)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting 0.83. At the close of trading, the stock’s price was $140.44, to imply an increase of 1.98% or $2.72 in intraday trading. The PODD share’s 52-week high ... best place to trade futures Insulet Corporation (NASDAQ:PODD) trade information. Sporting 3.82% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, 11/13/23 when the PODD stock …Research Insulet's (Nasdaq:PODD) stock key valuation metrics while comparing it with its industry peers & market side by side. Dashboard Markets Discover Watchlist Portfolios Screener. Insulet Corporation. NasdaqGS:PODD Stock Report. ... What is PODD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the ...Written by Zacks Equity Research for Zacks ->. Insulet PODD is scheduled to report third-quarter 2023 results on Nov 1, after market close. In the last reported quarter, the company’s adjusted ...